SCHEMBL16110808

SCHEMBL16110808

CC(C)[C@H](O)C(=O)[N@@+]1(C)CCC2CCC=CC2=C(NC(=O)[C@H](C)N)C1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6364242 0.84 XIAP (0.33)
SCHEMBL6364988 0.71 XIAP (0.33)
Hydrochloric Acid SCHEMBL6305086 0.70 XIAP (0.33)
Hydrochloric Acid SCHEMBL7424704 0.70 XIAP (0.33)
SCHEMBL7427846 0.68 PIK3CD (0.33)
Hydrochloric Acid SCHEMBL6309974 0.67 PIK3CD (0.33)
Hydrochloric Acid SCHEMBL7429831 0.67 PIK3CD (0.33)
SCHEMBL7425403 0.59 XIAP (0.33)
SCHEMBL8330682 0.51 TAAR1 (0.37)
SCHEMBL18675293 0.49 CCR2 (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023164171-A2 MULTILAYER IMPLANTABLE CELL ENCAPSULATION DEVICES AND METHODS THEREOF VIACYTE, INC. (US) 2023-08-31 WO disclosed
WO-2018129046-A1 COMPOSITIONS AND METHODS FOR MODULATING CILIOGENESIS UNIVERSITY OF PITTSBURGH- OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2018-07-12 WO disclosed
EP-2970899-A1 IN VITRO DIFFERENTIATION OF PLURIPOTENT STEM CELLS TO PANCREATIC ENDODERM CELLS (PEC) AND ENDOCRINE CELLS ViaCyte, Inc. (US) 2016-01-20 EP disclosed
WO-2014160413-A1 IN VITRO DIFFERENTIATION OF PLURIPOTENT STEM CELLS TO PANCREATIC ENDODERM CELLS (PEC) AND ENDOCRINE CELLS VIACYTE, INC. (US) 2014-10-02 WO disclosed